Heart disease in pregnancy

Babadjanova Guljakhon  Sattarovna; Uzakova Manzura  Kamilovna

doi:10.30574/gscbps.2021.15.3.0151

Authors

Babadjanova Guljakhon Sattarovna Obstetrics and gynecology Department of the Tashkent Medical Academy, Tashkent, Uzbekistan.
Uzakova Manzura Kamilovna Obstetrics and gynecology Department of the Tashkent Medical Academy, Tashkent, Uzbekistan.

DOI:

https://doi.org/10.30574/gscbps.2021.15.3.0151

Keywords:

Pregnancy, Cardiac disease, Heart failure, Birth

Abstract

Heart disease are common condition in pregnant women. Even, some of the cases diagnose just during the pregnancy. In this article, we summarize common cardiac disorders, which might encounter during the pregnancy and after birth. Furthermore, we discuss some etiological factors, pathophysiology, clinical manifestation, treatment and outcomes of the cardiac disease in pregnancy.

Metrics

Metrics Loading ...

References

Bekbaulieva GN, Abduraimova GA, Razzakova NS, Uzokov J. Influence of technologies of effective perinatal care on operating indicators of obstetric complexes. Journal of Critical Reviews. 2020; 7(9): 1182-1184.

Creanga AA, et al. Pregnancy-related mortality in the United States, 2006–2010.Obstetrics and Gynecology. 2015; 125(1): 5–12.

Ntiloudi D, et al. Adult congenital heart disease: a paradigm of epidemiological change. International Journal of Cardiology. 2016; 218: 269–74.

Alyavi A, Uzokov J. Treatment of stable angina pectoris: focus on the role of calcium antagonists and ACE inhibitors. Ont Health Technol Assess Ser. 2017; 15(9): 1-12.

Ahmedov I, et al. Features of hyperreninemic aldosteronism in hypertension patients with metabolic syndrome. Eur J Prev Card. 2016; 23(1).

Lutfullayevich AA, et al. Cardiovascular risk stratification and gender differences in hypertensive patients with metabolic syndrome. J Amer Col Card. 2017; 70(16): 138-139.

Mukhamedova M, et al. P120 Relationship between left ventricular global function index and cardiac systolic functions in patients with chronic ischemic disease of the heart and diabetes mellitus. Eur Heart J-Card Imag. 2019; 20(S3): 147, 008.

Usarov M, et al. Efficacy of Combination Therapy Using Nebivalol and Trimetazidine in Hypertensive Patients With Metabolic Syndrome And Stable Angina. J Hyperten. 2016; 34: e349.

Babaev M, et al. Influence of l-arginine aspartate on vascular markers in hypertensive patients with metabolic syndrome. Eur Heart J. 2018; 39: 495-495.

Alyavi AL, et al. Predictors of contrast induced nephropathy in patients with metabolic syndrome. Eur Heart J. 2017; 38: 1283-1283.

Uzokov J. Influence of abnormal lipid components in statin-naive young adults: Is there any gap? Eur J Prev Card. 2020; 27(8): 868–869.

Mamatkulov, KhA, Usarov MH, Uzokov ZhK, Arzieva, JB. Influence of interventional myocardial revascularization in patients with acute myocardial infarction without “q” wave. O 'zbekiston terapiya axborotnomasi. 2015; 2: 18.

Uzokov JK, Alyavi BA, Abdullaev AX. Assessment of the clopidogrel action with regard to CYP2C19 gene polymorphisms in patients with coronary artery disease after implantation of des stents. Euroasian Card J. 2019; S2: 309-309.

Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiology Clinical. 2012; 30(3): 317–29.

Alyavi B, Uzokov J, Abdullaev A, Payziev D and Muxitdinova O. Influence of Diet with Low Glycemic Index on Pro-inflammatory Interleukins in Patients with Metabolic Syndrome and Coronary Artery Disease. Metabolism-Clinical and Experimental. 2021; 116.

Alyavi A, Alyavi B, Uzokov J. Prognostic value of metabolic syndrome for the development of type 2 diabetes mellitus and cardiovascular disease. Atherosclerosis. 2020; 315: e180.

Payziev D, Azizov SI, Uzokov JK, Iskhakov SA. P1003 New onset atrial fibrillation after stenting of the right coronary artery in patients with ischemic disease of the heart. EP Europace. 2020; 22(S1): 162-338.

Uzokov J, Alyavi B. Efficacy of clopidogrel in patients with coronary artery disease after PCI considering with genetic polymorphisms. Atherosclerosis. 2020; 315: e84.

Uzokov J, Alyavi B, Payziev D. Influence of diet with low glycemic index on triglycerides, glycated hemoglobin and LDL-C/HDL-C ratio in patients with coronary artery disease. Atherosclerosis. 2020; 315: e253.

Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Broughton D. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. The Lancet. 2018; 391(10123): 850-859.

Araiza-Garaygordobil D, Montalto C, Martinez-Amezcua P, Cabello-Lopez A, Gopar-Nieto R, Alabrese R, Tavazzi G. Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study. QJM: An International Journal of Medicine. 2021; 1-6.

Uzokov J, Alyavi B, Abdullaev A. Influence of combined lipid lowering therapy on lipid components and interleukins in dyslipidemic patients with coronary artery disease after PCI. Atherosclerosis. 2020; 315: e280.

Matić I, Froelicher ES, Uzokov J, Ljubas A. A Survey on Cardiovascular Nursing Occupational Standard: Meeting the Needs of Employers. Policy, Politics, & Nursing Practice. 2020.

Uzokov JK, Alyavi BA, Abdullaev AX. Assessment of the clopidogrel action with regard to CYP2C19 gene polymorphisms in patients with coronary artery disease after implantation of des stents. Euroasian Card J. 2019; S2: 309-309.

Alyavi B, Uzokov JK, Abdullaev AX, Payziev DD. P427 Influence of ranolazine on cardioversion rate in patients with new onset atrial fibrillation and ischemic disease of the heart. EP Europace. 2020; 22(S1): 162-337.

Alyavi AL, Alyavi BA, Uzokov J, Abdullaev AX. P1001 Efficacy of ranolazine for the prevention of atrial fibrillation in high-risk patients with chronic coronary syndrome and hypertension. EP Europace. 2020; 22(1): 162-354.

Uzokov J, Alyavi A, Alyavi B, Azizov S. Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome. European Cardiology Review. 2020; 15.

Gafurjanovna MM, Saidjanovna ND, Jamol U. Efficacy of rosuvastatin on lipid parameters and vascular and inflammatory markers in patients with metabolic syndrome and coronary artery disease. Journal of Critical Reviews. 2020; 7(19): 8112-8115.

Alyavi A, Alyavi B, Tulyaganova D, Sabirjanova Z, Nuritdinova S, Kayumova N, Uzokov J. Tumor necrosis factor-α and interleukin-6 gene distribution in patients with coronary heart disease. Journal of Critical Reviews. 2020; 7(19): 7441-7449.

Uzokov J. Condition of coronary arteries and change of lipid profile in coronary heart. Age. 2020; 62(7): 3-09.

Uzokov J, Alyavi AL, Alyavi BA, Iskhakov SA, and Payziev DD. P3570 Bilateral renal artery stenting is effective method for the treatment of uncontrolled hypertension and renal function. European Heart Journal. 2019; 40(1): ehz745-0432.

Abdullaev AH, Alyavi BA, Iskhakov SHA, Uzakov ZhK, Ibabekova ShR, Yunusova LI, Azizov ShI. Some indicators of biochemical studies and echocardiography of patients with coronary heart disease who underwent stenting. In VI Eurasian Congress of Cardiology. 2018; 76.

Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A, Cosyns B. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Heart J-Qual C Clin Out. 2019; 5(3): 202-207.

Uzokov JK, Alyavi AL, Alyavi BA, Kayumov NU. P269 Prognostic role of coronary artery calcium score in patients with metabolic syndrome. European Heart Journal-Cardiovascular Imaging. 2019; 20(3): jez148-001.

Alyavi A, et al. Influence of Diet with Low Glycemic Index on Lipid Spectrum in Patients with Ischemic Disease of the Heart. Atherosclerosis Supplements. 2018; (32): 158.

Radjabova DI, Alyavi AL, Alyavi BA, Tulyaganova DK, Uzokov JK, Shodiev JD, Nuritdinova SK. The Features of Cytokine Status in Patients with Coronary Heart. 2018.

Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014; 130(12): 1003–8.

Hinze A, et al. Reproductive and contraceptive counseling received by adult women with congenital heart disease: a risk-based analysis. Congenital Heart Disease. 2013; 8(1): 20–31.

Orwat S, et al. Risk of pregnancy in moderate and severe aortic stenosis: from the multinational ROPAC Registry. Journal of the American College of Cardiology. 2016; 68(16): 1727–37.

Brickner ME. Cardiovascular management in pregnancy: congenital heart disease. Circulation. 2014; 130(3): 273–82.